Knight Cancer Institute

Research Output 1990 2019

Filter
Letter
2019

Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy

Lachowiez, C., Kearney, M., Meyers, G., Maziarz, R. & Cook, R. J., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Induction Chemotherapy
Health Expenditures
Delivery of Health Care

Long-term stroke risk in meningioma patients treated with conventionally fractionated photon-based radiation therapy

McClelland, S., Mitin, T., Kubicky, C. D. & Jaboin, J., Jan 1 2019, In : Journal of Radiosurgery and SBRT. 6, 1, p. 77-79 3 p.

Research output: Contribution to journalLetter

Meningioma
Photons
Radiotherapy
Stroke
2018

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

Watanabe-Smith, K., Druker, B., Tyner, J. & Edwards, D. K., Jul 31 2018, In : Haematologica. 103, 8, p. e351-e355

Research output: Contribution to journalLetter

Decision Trees
Acute Myeloid Leukemia

Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?

Shanbhag, S. & Prasad, V., Nov 1 2018, In : European Journal of Cancer. 104, p. 252-253 2 p.

Research output: Contribution to journalLetter

Hodgkin Disease
Costs and Cost Analysis
cAC10-vcMMAE
1 Citation (Scopus)

Cost-effectiveness of nusinersen for spinal muscular atrophy: Reply

Prasad, V., Jul 1 2018, In : JAMA Pediatrics. 172, 7, p. 701-702 2 p.

Research output: Contribution to journalLetter

Spinal Muscular Atrophy
Cost-Benefit Analysis
1 Citation (Scopus)

Crossover is not associated with faster trial accrual

Chen, E. Y. & Prasad, V., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 776-777 2 p., mdx821.

Research output: Contribution to journalLetter

3 Citations (Scopus)

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Pianko, M. J., Funt, S. A., Page, D. B., Cattry, D., Scott, E., Ansell, S. M., Borrello, I. M., Gutierrez, M., Lendvai, N., Hassoun, H., Landgren, C. O. & Lesokhin, A. M., Jan 2 2018, In : Leukemia and Lymphoma. 59, 1, p. 221-224 4 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Inconsistent reporting of potential conflicts of interest

Prasad, V., Jul 24 2018, In : JAMA - Journal of the American Medical Association. 320, 4, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest
1 Citation (Scopus)

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA oncology. 4, 10, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA Internal Medicine. 178, 10, p. 1424-1425 2 p.

Research output: Contribution to journalLetter

Conflict of Interest

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Sep 1 2018, In : JAMA Pediatrics. 172, 9, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest
2 Citations (Scopus)

In Regard to Palmer et al

McClelland, S. & Jaboin, J., Jul 15 2018, In : International Journal of Radiation Oncology Biology Physics. 101, 4, p. 999-1000 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In Regard to Sura et al

McClelland, S. & Jaboin, J., Oct 1 2018, In : International Journal of Radiation Oncology Biology Physics. 102, 2, p. 468-469 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

In reply

Mailankody, S. & Prasad, V., Apr 1 2018, In : JAMA oncology. 4, 4, p. 586-587 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In reply

Prasad, V., Kaestner, V. & Mailankody, S., Sep 1 2018, In : JAMA oncology. 4, 9, p. 1300-1301 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In reply

Prasad, V. & Mailankody, S., Apr 1 2018, In : JAMA Internal Medicine. 178, 4, p. 588-589 2 p.

Research output: Contribution to journalLetter

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory waldenström macroglobulinemia: Evidence for a graft-versus-lymphoma effect

Maffini, E., Anderson, L. D., Sandmaier, B. M., Green, D. J., Storer, B. E., Niederwieser, D., Maziarz, R., Maloney, D. G. & Storb, R., Jun 3 2018, In : Haematologica. 103, 6, p. e252-e255

Research output: Contribution to journalLetter

Waldenstrom Macroglobulinemia
Cell Transplantation
Lymphoma
Transplants
Anterior Temporal Lobectomy
Temporal Lobe Epilepsy
African Americans
Therapeutics

The Radiation Safety of 5G Wi-Fi: Reassuring or Russian Roulette?

McClelland, S. & Jaboin, J., Aug 1 2018, In : International Journal of Radiation Oncology Biology Physics. 101, 5, p. 1274-1275 2 p.

Research output: Contribution to journalLetter

safety
Radiation
Safety
radiation
12 Citations (Scopus)

Total costs of chimeric antigen receptor T-cell immunotherapy

Hernandez, I., Prasad, V. & Gellad, W. F., Jul 1 2018, In : JAMA oncology. 4, 7, p. 994-996 3 p.

Research output: Contribution to journalLetter

T-Cell Antigen Receptor
Immunotherapy
Costs and Cost Analysis
2017
1 Citation (Scopus)

A further strategy to combat the high price of anticancer drugs

Prasad, V., De Jesús, K. & Mailankody, S., Oct 1 2017, In : Nature Reviews Clinical Oncology. 14, 10, 1 p.

Research output: Contribution to journalLetter

Pharmaceutical Preparations
2 Citations (Scopus)

Clinically meaningful benefit: Real world use compared against the American and European guidelines

Dreicer, J. J., Mailankody, S., Fahkrejahani, F. & Prasad, V., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 645.

Research output: Contribution to journalLetter

Guidelines
1 Citation (Scopus)
Large Granular Lymphocytic Leukemia
Hematopoiesis
Mutation
2 Citations (Scopus)

Conflicts of interest in Twitter

Kaestner, V., Brown, A., Tao, D. & Prasad, V., Sep 1 2017, In : The Lancet Haematology. 4, 9, p. e408-e409

Research output: Contribution to journalLetter

Conflict of Interest
3 Citations (Scopus)

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma

Scott, E., Maziarz, R., Spurgeon, S., Medvedova, E., Gajewski, J., Reasor-Heard, S., Park, B., Kratz, A., Thomas, G., Loriaux, M., Cascio, M., Podolak, J., Gordon, M., Botelho, J., Stadtmauer, E., Amaravadi, R. & Vogl, D. T., Jun 26 2017, In : Haematologica. 102, 7, p. e261-e265

Research output: Contribution to journalLetter

1 Citation (Scopus)

Financial conflicts of interest among editorialists in high-impact journals

Kaestner, V. & Prasad, V., Sep 15 2017, In : Blood Cancer Journal. 7, 9, p. e611

Research output: Contribution to journalLetter

Conflict of Interest
13 Citations (Scopus)

Financial conflicts of interest among hematologist-oncologists on Twitter

Tao, D. L., Boothby, A., McLouth, J. & Prasad, V., Mar 1 2017, In : JAMA Internal Medicine. 177, 3, p. 425-427 3 p.

Research output: Contribution to journalLetter

Conflict of Interest
Oncologists
Adult T Cell Leukemia Lymphoma
Therapeutics
2 Citations (Scopus)

In reply

Beer, T. T. & Prasad, V., Nov 1 2017, In : JAMA oncology. 3, 11, p. 1588-1589 2 p.

Research output: Contribution to journalLetter

Is it time to convert the frequency of radiotherapy in small-cell lung cancer?

Mitin, T., Farrell, M., Holland, J., Cetnar, J. & Thomas, C., Oct 1 2017, In : The Lancet Oncology. 18, 10, p. e554

Research output: Contribution to journalLetter

Small Cell Lung Carcinoma
Radiotherapy
Hematology
Industry
Medicine
3 Citations (Scopus)

Recurrent cyclin D2 mutations in myeloid neoplasms

Khanna, V., Eide, C. A., Tognon, C. E., Maxson, J., Wilmot, B., Bottomly, D., McWeeney, S., Edwards, V. D. K., Druker, B. & Tyner, J., Sep 1 2017, In : Leukemia. 31, 9, p. 2005-2008 4 p.

Research output: Contribution to journalLetter

8 Citations (Scopus)

The rising price of cancer drugs- a newold problem?

Prasad, V., Wang, R., Afifi, S. H. & Mailankody, S., Feb 1 2017, In : JAMA oncology. 3, 2, p. 277-278 2 p.

Research output: Contribution to journalLetter

Pharmaceutical Preparations
Neoplasms
1 Citation (Scopus)
Drug Approval
Publications
Food
Pharmaceutical Preparations
Neoplasms
1 Citation (Scopus)

To the editor

Friedberg, M. W., Gellad, W. F. & Prasad, V., Jul 1 2017, In : JAMA Internal Medicine. 177, 7, p. 1058 1 p.

Research output: Contribution to journalLetter

To the Editor

Redberg, R. F. & Prasad, V., Aug 24 2017, In : New England Journal of Medicine. 377, 8, p. 786-787 2 p.

Research output: Contribution to journalLetter

2016

Acute inflammatory skin reaction during neutrophil recovery after antileukemic therapy

Roengvoraphoj, M., Yan, S., Lansigan, F., Chapman, M. S. & Danilov, A., 2016, In : Cutis. 98, 4, p. E13-E15

Research output: Contribution to journalLetter

Chemotherapy-Induced Febrile Neutropenia
Sweet Syndrome
Mitoxantrone
Acute Promyelocytic Leukemia
Tretinoin
3 Citations (Scopus)

Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia

Watanabe-Smith, K., Tognon, C., Tyner, J., Meijerink, J. P. P., Druker, B. & Agarwal, A., Sep 1 2016, In : Leukemia. 30, 9, p. 1950-1953 4 p.

Research output: Contribution to journalLetter

6 Citations (Scopus)

Future jobs of FDA's haematology-oncology reviewers

Bien, J. & Prasad, V., 2016, In : BMJ (Online). 354, i5055.

Research output: Contribution to journalLetter

Hematology
7 Citations (Scopus)

Industry Funding of Cancer Patient Advocacy Organizations

Abola, M. V. & Prasad, V., Nov 1 2016, In : Mayo Clinic Proceedings. 91, 11, p. 1668-1670 3 p.

Research output: Contribution to journalLetter

Patient Advocacy
Industry
Organizations
Neoplasms
4 Citations (Scopus)

Survival trends in T cell prolymphocytic leukemia: A SEER database analysis

Chandran, R., Gardiner, S. K., Fenske, T. S. & Spurgeon, S., Apr 2 2016, In : Leukemia and Lymphoma. 57, 4, p. 942-944 3 p.

Research output: Contribution to journalLetter

T-Cell Prolymphocytic Leukemia
Population Surveillance
SEER Program
Kaplan-Meier Estimate
Databases
19 Citations (Scopus)

The Use of Superlatives in Cancer Research

Abola, M. V. & Prasad, V., Jan 1 2016, In : JAMA oncology. 2, 1, p. 139-141 3 p.

Research output: Contribution to journalLetter

Marketing of Health Services
Consumer Health Information
Mass Media
Antineoplastic Agents
Biomedical Research